Kemp Proteins Selected by Avivo Biomedical to Support Process Optimization for Universal Blood Technology Program
FREDERICK, Md., June 2, 2026 /PRNewswire/ -- What if blood type compatibility was no longer a limiting factor in emergency medicine, trauma response, or organ transplantation? That is the future Avivo Biomedical Inc. is working toward through its pioneering universal blood technology...
FREDERICK, Md., June 2, 2026 /PRNewswire/ -- What if blood type compatibility was no longer a limiting factor in emergency medicine, trauma response, or organ transplantation? That is the future Avivo Biomedical Inc. is working toward through its pioneering universal blood technology...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.